In light of the cost and considerable notice period associated with holding such general meetings to be able to ratify or approve capacity to issue equities, the Board has also included a resolution seeking approval to issue up to 800 million shares associated with a potential placement.
The resolution provides the Board with the flexibility to rapidly make an institutional placement to sophisticated sector focused investors, at the Board’s discretion, without the need to revert to shareholders for approval at a further EGM and the associated delay. If approved, any shares under such placement must be issued within three months of the Meeting. The funds raised under the placement would support the clinical trial pipeline and otherwise for general working capital of the Company.
I'm thinking CHM 1101 is looking good and the potential placement is for a potential partner. They'll use the cash to progress CHM 2101.
Thoughts?
- Forums
- ASX - By Stock
- CHM
- Ann: Notice of Extraordinary General Meeting/Proxy Form
Ann: Notice of Extraordinary General Meeting/Proxy Form, page-3
-
- There are more pages in this discussion • 282 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.40M |
Open | High | Low | Value | Volume |
1.5¢ | 1.5¢ | 1.5¢ | $7.588K | 505.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 1919600 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 28828 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 1919600 | 0.015 |
7 | 912261 | 0.014 |
4 | 710769 | 0.013 |
3 | 83416 | 0.012 |
4 | 279041 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 28828 | 1 |
0.017 | 617827 | 2 |
0.018 | 510000 | 4 |
0.019 | 1948702 | 6 |
0.020 | 1223093 | 5 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |